Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ClearPoint Neuro Inc. - Common Stock
(NQ:
CLPT
)
9.140
-0.110 (-1.19%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 23, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ClearPoint Neuro Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List
↗
February 09, 2024
These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.
Via
InvestorPlace
3 Small-Cap Healthcare Stocks to Buy and Hold Forever: January 2024
↗
January 25, 2024
Small-cap healthcare stocks combine relative cheapness with advanced innovations including AI, automation, and more.
Via
InvestorPlace
Topics
Artificial Intelligence
7 Small-Cap Stocks With Huge Potential Flying Under the Radar
↗
January 10, 2024
Small-cap stocks are massively undervalued and represent a unique investment opportunity for traders in 2024.
Via
InvestorPlace
7 Solid Small-Caps for 2024 and Beyond
↗
December 05, 2023
Small-cap stocks are positioned to beat the biggest companies in 2024 as risk tolerance climbs and shares remain undervalued
Via
InvestorPlace
ClearPoint Neuro: Q3 Earnings Insights
↗
November 09, 2023
Via
Benzinga
ClearPoint Neuro: Q1 Earnings Insights
↗
May 11, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
↗
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
ClearPoint Neuro Secures FDA Nod For ClearPoint Prism Neuro Laser Therapy System
↗
September 23, 2022
Via
Benzinga
FDA Approves ClearPoint Neuro's Updated Software For Guidance System For Neurological Procedures
↗
September 20, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
↗
October 24, 2023
Via
Benzinga
Top 5 Health Care Stocks That Are Set To Fly In Q2
↗
June 09, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
June 05, 2023
Monday's session saw 41 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
July 28, 2023
Friday's session saw 59 companies set new 52-week lows.
Via
Benzinga
3 High-Potential Small-Cap Stocks for Investors With Strong Stomachs
↗
May 31, 2023
Small-cap stocks can be risky, and all three of these companies are facing adversity. But they could be home run investments.
Via
InvestorPlace
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
May 24, 2023
From
ClearPoint Neuro, Inc.
Via
GlobeNewswire
3 Healthcare Stocks With Huge Growth Potential
↗
April 24, 2023
It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead.
Via
InvestorPlace
ClearPoint Neuro's Earnings: A Preview
↗
November 07, 2022
ClearPoint Neuro (NASDAQ:CLPT) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that ClearPoint...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
October 18, 2022
It's time for another look at the biggest pre-market stock movers as we check out what's happening with shares on Tuesday morning!
Via
InvestorPlace
ClearPoint Neuro: Q2 Earnings Insights
↗
August 09, 2022
ClearPoint Neuro (NASDAQ:CLPT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings ClearPoint Neuro reported...
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End Of the Day Summary
↗
August 09, 2022
Via
Benzinga
ClearPoint Shares Climb as FDA Announced Clearance To Maestro Brain Model Software
↗
August 09, 2022
ClearPoint Neuro (NASDAQ: CLPT) announced the U.S. Food and Drug Administration (FDA) 510(k) clearance to its Maestro Brain Model, intended for automatic labeling, visualization, volumetric and shape...
Via
Benzinga
ClearPoint Neuro's Return On Capital Employed Insights
↗
June 15, 2022
According to data from Benzinga Pro, during Q1, ClearPoint Neuro's (NASDAQ:CLPT) reported sales totaled $5.03 million. Despite a 4.58% increase in earnings, the company posted a loss of $3.96 million.
Via
Benzinga
Again, Buy ‘Em
↗
May 31, 2022
Today we discuss again why it’s time to start adding back risk. We cover the major breadth thrusts that fired, some great monthly charts, and more.
Via
Talk Markets
38 Stocks Moving In Friday's Mid-Day Session
↗
May 20, 2022
Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413.
Via
Benzinga
66 Biggest Movers From Friday
↗
May 23, 2022
Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 11, 2022
Gainers
Via
Benzinga
90 Biggest Movers From Yesterday
↗
May 13, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...
Via
Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
↗
May 12, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Via
Benzinga
Recap: ClearPoint Neuro Q1 Earnings
↗
May 11, 2022
ClearPoint Neuro (NASDAQ:CLPT) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings ClearPoint Neuro beat...
Via
Benzinga
ClearPoint Neuro: Q4 Earnings Insights
↗
March 01, 2022
ClearPoint Neuro (NASDAQ:CLPT) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
